Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Rhoen Klinikum AG's Enterprise Value is €715 Mil.
Rhoen Klinikum AG's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was €55 Mil. Therefore, Rhoen Klinikum AG's EV-to-EBIT ratio for today is 12.98.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Rhoen Klinikum AG's Enterprise Value is €715 Mil.
Rhoen Klinikum AG's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was €120 Mil. Therefore, Rhoen Klinikum AG's EV-to-EBITDA ratio for today is 5.95.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Rhoen Klinikum AG's Enterprise Value is €715 Mil.
Rhoen Klinikum AG's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was €1,726 Mil. Therefore, Rhoen Klinikum AG's EV-to-Revenue ratio for today is 0.41.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Rhoen Klinikum AG (WBO:RHK) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Rhoen Klinikum AG's current Enterprise Value is €715 Mil.
Rhoen Klinikum AG's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €55 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Rhoen Klinikum AG's current Enterprise Value is €715 Mil.
Rhoen Klinikum AG's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €120 Mil.
Rhoen Klinikum AG's current Enterprise Value is €715 Mil.
Rhoen Klinikum AG's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,726 Mil.
Rhoen Klinikum AG's current Enterprise Value is €715 Mil.
Rhoen Klinikum AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.
Rhoen Klinikum AG's current Enterprise Value is €715 Mil.
Rhoen Klinikum AG's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rhoen Klinikum AG Enterprise Value Related Terms
Rhoen Klinikum AG Enterprise Value Historical Data
* Premium members only.
The historical data trend for Rhoen Klinikum AG's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:RHK vs HCA, THC, DVA: Enterprise Value Comparison
For the Medical Care Facilities subindustry, Rhoen Klinikum AG's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rhoen Klinikum AG Enterprise Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Rhoen Klinikum AG's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Rhoen Klinikum AG's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Rhoen Klinikum AG's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rhoen Klinikum AG (WBO:RHK) has a Enterprise Value of €715 Mil as of Jul. 11, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Rhoen Klinikum AG and its competitors.
Is Rhoen Klinikum AG's Enterprise Value too high?
Rhoen Klinikum AG's current Enterprise Value is €715 Mil. Overall, Rhoen Klinikum AG has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Rhoen Klinikum AG's Enterprise Value compare to HCA and THC?
Rhoen Klinikum AG's Enterprise Value of €715 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Providers & Services company?
A good Enterprise Value depends on the Healthcare Providers & Services industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Rhoen Klinikum AG and its competitors. Rhoen Klinikum AG's current Enterprise Value is €715 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhoen Klinikum AG stock overvalued right now?
Rhoen Klinikum AG (WBO:RHK) has a current Enterprise Value of €715 Mil. The stock's GF Value™ is €13.69, compared to a current price of €13.30 — trading 2.8% below its estimated fair value. The current Enterprise Value is €715 Mil. Rhoen Klinikum AG's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Rhoen Klinikum AG (WBO:RHK), the current Enterprise Value is €715 Mil as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rhoen Klinikum AG (WBO:RHK) Overvalued in 2026?
Based on GuruFocus' analysis, Rhoen Klinikum AG stock appears to be undervalued.
The current stock price of €13.30 is trading 2.8% below its estimated GF Value™ of €13.69.
Key valuation signals for WBO:RHK:
Enterprise Value: €715 Mil
GF Value™: €13.69 vs. price of €13.30 (2.8% below fair value)
No single metric tells the full story. See the WBO:RHK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rhoen Klinikum AG provides medical care and healthcare services. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on inpatient, semi-inpatient and outpatient healthcare basis. The company generates the entire revenue in Germany, with the Bavaria and Hesse regions contributing the majority proportions of revenue.
74GF Score
Get the complete analysis for WBO:RHK
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:RHK has been successfully added to your 
